Novavax COVID-19 Vaccine Associated With Heart Inflammation: Study

• Novavax COVID-19 Vaccine Associated With Heart Inflammation: Study
  by Zachary Stieber, https://www.theepochtimes.com/health
  A higher-than-expected number of heart inflammation cases have occurred in people who received Novavax’s COVID-19 vaccine, researchers reported in a new study. Sixty-one cases of myocarditis, pericarditis, or both following a Novavax vaccination were reported in the World Health Organization’s vaccine safety database through Aug. 23, 2022, Spanish researchers found.
  –
  Using pre-pandemic rates of heart inflammation in the population, the researchers calculated that the number of postvaccination cases was higher than expected. Reporting odds ratio values of higher than one indicate a higher-than-expected rate. For myocarditis following the Novavax vaccination, the ratio was 5.2. For pericarditis, it was 24.75. For myopericarditis, or both conditions at once, it was 14.4.
  –
  Heart inflammation is a known side effect of the Pfizer and Moderna COVID-19 vaccines, which utilize messenger RNA (mRNA) technology, but little data has been collected on the condition following the Novavax vaccination, which doesn’t contain mRNA.
  –
  read more.

end